https://pharmoniq.com/news/fda-approves-centanafadine-simtriyo-triple-reuptake-inhibitor-adhd PharmoniQ en 2026-08-17T14:10:49.833Z FDA Approves Centanafadine as First Triple Reuptake Inhibitor for ADHD ADHD, FDA approval, centanafadine, neurotransmitters, psychiatric medications https://pharmoniq.com/news/fda-warning-toxic-yellow-oleander-dietary-supplements PharmoniQ en 2026-08-16T14:10:49.750Z FDA Issues Urgent Warning on Toxic Yellow Oleander in Supplements FDA warning, yellow oleander, supplement contamination, cardiac toxicity, supplement safety https://pharmoniq.com/news/food-to-live-green-powder-salmonella-recall-2024 PharmoniQ en 2026-08-16T08:47:02.837Z Food To Live Recalls 9 Green Powders After 45 Salmonella Cases salmonella, product recall, green powders, food safety, FDA